Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 23, 2026.

Oxidative Stress in Cognitive and Epigenetic Aging: A Retrospective Glance

Aditi Kandlur, Kapaettu Satyamoorthy, Gireesh Gangadharan

Frontiers in Molecular Neuroscience · 2020 · Review · CC BY

doi:10.3389/fnmol.2020.00041

Abstract

Brain aging is the critical and common factor among several neurodegenerative disorders and dementia. Cellular, biochemical and molecular studies have shown intimate links between oxidative stress and cognitive dysfunction during aging and age-associated neuronal diseases. Brain aging is accompanied by oxidative damage of nuclear as well as mitochondrial DNA, and diminished repair. Recent studies have reported epigenetic alterations during aging of the brain which involves reactive oxygen species (ROS) that regulates various systems through distinct mechanisms. However, there are studies which depict differing roles of reactive oxidant species as a major factor during aging. In this review, we describe the evidence to show how oxidative stress is intricately linked to age-associated cognitive decline. The review will primarily focus on implications of age-associated oxidative damage on learning and memory, and the cellular events, with special emphasis on associated epigenetic machinery. A comprehensive understanding of these mechanisms may provide a perspective on the development of potential therapeutic targets within the oxidative system.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 23, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Aging involves the systemic loss of functioning in a time-dependent manner. There is increased focus on deciphering the mechanisms that prevail during aging. This is due to the increase in the life expectancy of individuals over these past few decades. The World Population Prospects 2019 report states an increase in the average life expectancy at birth to 72.6 years in 2019. The same report indicates that by 2050, the global number of individuals aged 65 years and more, will surpass the number of youths aged 15 to 24 years. The number of older individuals is projected to grow more than double the number of children below 5 years of age, by 2050. Aging is a key factor in several neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. An aging brain is reported to show more cases of amyloid plaques, α-synuclein accumulation, loss of brain volume, loss of neurons, and neurofibrillary tangles. The hippocampus and the frontal lobes are the most commonly affected brain regions, therefore bringing about observable phenotypes pertaining to cognition, learning, memory, and attention. Brain being a metabolically robust active organ, is a large consumer of oxygen as well as producer of reactive oxygen species (ROS). Although there are many theories to explain the mechanism of aging, the free radical theory forms a basis to explain a great deal about how the reactive oxidants interact with the components of the cells to bring about a long-lasting accumulated damage and result in aging. There seems to be a converging viewpoint regarding the epigenetic machinery that would be influenced by the changes in the oxidative microenvironment of cells. However, with the role of a double-edged sword, reactive oxidant species proves to be a necessary evil which also has been shown to be involved in various essential functions of the neuronal cells such as polarization of neurons, neurite outgrowth and axon specification, activity-induced synaptic growth and plasticity. This review will highlight the roles played by the oxidative environment in the cells as aging proceeds and how it affects learning and memory as well as its significance in neurodegenerative diseases. The review will also include the underlying cellular events with an emphasis on the associated epigenetic machinery.

Oxidative Stress and Cognitive Aging

Cognition is the collective set of abilities that involves various information processing, storage, and retrieval. This envelopes the concept of intelligence or metacognition, which involves the capacity to learn from experience and the ability to adapt to the surrounding environment or situations. There is a visible deterioration in cognition in aged individuals, in terms of fluid abilities or intelligence. This involves the application of crystallized abilities (skills and memories that are acquired) based on context/situation. These cognitive abilities that decline with age include attention, language skills, executive cognitive function, visuospatial abilities (perceiving spatial orientation of objects and visuoperceptual judgment), and certain types of memory such as working memory, prospective memory (to remember to perform a task in future) among others. There is also a well-defined and gradual decline in learning capacities. There are variations in the course of cognitive aging due to genetic as well as environmental factors. Such factors affect the cell’s characteristic resilience to accumulation of damage that are brought about by stressors of aging. In terms of memory, episodic memory is the most effected with aging. This type of memory would include the memories of events in a spatio-temporal context (where and when it occurred) and with aging, retrieval becomes more difficult. On the other hand, semantic memory that covers memory of general knowledge of vocabulary, facts, etc. which does not require quick retrieval actions are retained quite well. The hippocampus of the limbic system is the critical focal point or structure for the cognitive aspects such as acquiring information (learning), consolidation and recall of declarative (episodic and semantic) memories. It is an important region concerned in the spatial memory maps formation. The loss of memory retention and recall may be due to age dependent loss of hippocampal functioning. The memory in the hippocampus is presumed to be time-limited, in the manner that it stores memories fast and also undergoes faster overwriting, this in turn might represent a higher decay rate of such aspects of memory. However, the remote memory remains to be integrated into the neocortical regions, with the ventromedial prefrontal cortex becoming a major sector for memory consolidation in the limbic system-cortex axis. This decline in cognitive abilities that accompanies aging may be partly due to brain atrophy that occurs in the temporal and frontal regions.

Oxidative stress and its associated damage being involved in the age-dependent cognitive loss have been highlighted through numerous investigations to be the basis of pathogenesis. Comparison between young and aged animal brains showed higher levels of ROS and oxidative stress markers. The appearance of behavioral deficits or cognitive impairments in temporal and spatial memory, learning and retention of memory displayed strong associations with increasing oxidative species and stress in aged animal models.

The conditions that prevail during aging are higher levels of oxidant species, oxidative stress and a shortfall in the antioxidant levels. To counter the effects of drop in antioxidant levels, the aged mice models that overexpress extracellular superoxide dismutase (EC-SOD) showed alleviation in spatial learning and memory related hippocampal long-term potentiation (LTP) that declines with age. They also showed better working memory as well as retention capacities when compared to the aged wild-type mice. On the other hand, to counter the effects of ROS, an antioxidant rich diet was able to reverse metabolic deficiencies of ascorbic acid, arachidonic acid, α-tocopherol. It even decreased the age-associated increase in the SOD activity, lipid peroxidation as well as inflammatory cytokine IL-1β. This might suggest the oxidative stress due to changes in the cellular environment might have an impact on the LTP. Age-associated cognitive impairment in terms of object recognition and associative fear memory has been observed in the klotho mouse model of aging. These mice showed higher levels of oxidative damage in lipid and DNA in the hippocampus and cerebral cortex. They also showed increased activity of antioxidants Cu/Zn-SOD and glutathione peroxidase (GPx) to compensate the increased ROS levels, the hippocampus also showed higher apoptotic gene expression. These mice when treated with α-tocopherol showed recovery of memory and reduced lipid peroxidation as well as cell death in the hippocampus, indicating oxidative stress caused apoptosis which later progressed into memory impairment. A similar study with aging rats and vitamin E deficient rats showed decreased learning as well as memory retention ability whereas younger rats supplemented with vitamin E displayed accelerated learning and capabilities. This could be that the learning ability declined gradually during aging due to chronic exposure to oxidative stress. The decrease in the memory retention capacity was due to oxidative stress induced delayed type of apoptosis that was observed in the CA1 hippocampal region. Vitamin E administration ameliorated the memory deficit. The vitamin E deficient rats showed higher levels of thiobarbituric acid reactive substances (TBARS), lipid hydroperoxides and protein carbonyls in the synaptic membranes. Synaptic membranes showed decreased ζ-potential causing a deficit in depolarization of the membrane and causing faulty neurotransmission. Another study highlighted increased oxidative stress with aging in terms of increased TBARS with corresponding increase in Cu/Zn-SOD and mitochondrial Mn-SOD activity. The aged mice also displayed impaired mitochondrial electron transfer in certain complexes- complex I and III (brain NADH-cytochrome c reductase), complex IV (brain cytochrome oxidase) and brain citrate synthase. The study describes that neurodegeneration and longevity can be predicted through the neuromuscular functioning and the oxidative stress markers. It highlights the existence of a relationship between the oxidative stress and the behavioral performance in terms of exploration. In the case of apoE knockout studies, it has been observed that there is a combined influence on cognitive aging through systemic oxidative stress and inflammatory vascular dysfunction. The age-related impairment of cognition involved oxidative molecular damages in the brain being one of the factors implicating cortical involvement. The same study established that the functional associations fall short to establish causal links that oxidative damage alone is able to cause age associated cognitive decline. Oxidative stress causing damage to mitochondria has been recently been implicated in neuronal degeneration as well as decline in cognition in Alzheimer’s subjects. In case of implicated neurons in Alzheimer’s, oxidative damage is brought about by the free radicals generated by the entry of mutant APP and soluble Aβ into mitochondria and cause further impair mitochondrial metabolism. Mild cognitive impairment (MCI) patient samples that precedes Alzheimer’s shows a vast amount of oxidative damage in the brain in terms of lipid peroxidation, protein carbonyls, and malondialdehyde. Another study showed a strong correlation between decreased antioxidant levels and increased lipid peroxidation, also stating that the depleted antioxidant systems may be the end result of the increased oxidant species levels. Large scale cohort studies in humans such as EVA revealed a strong link as to oxidative stress being involved in cognitive decline with aging.

Cellular and Molecular Implications of Oxidative Aging

A prominent sign of an aging cell is the imbalance between the constantly produced reactive oxidant species and the diminishing antioxidant capacity. To have a better outlook on the role of oxidative stress during normal aging as well as disease conditions such as neurodegenerative disorders that accompany aging, we here discuss various levels of implications imposed by aging in the oxidative microenvironment- cellular, organellar, genetic as well as epigenetic.

Oxidative Damage Sources and Their Implications

DNA is an important carrier of heritable genetic information that faces the limitation of chemical stability that is constantly prone to changes. Considering the large genome size and the slower rate of replication when compared to the prokaryotes, it can be estimated that human cells have a turnover rate of 2,000–10,000 DNA purine bases on a daily basis due to hydrolytic depurination followed by excision repair. In this context, it has been hypothesized that long-lived, non-dividing human nerve cells would lose ∼108 purines or ∼3% of its total purine residues from its DNA in an individual’s lifetime.

DNA undergoes oxidative damage due to a series of sources reactive oxygen and nitrogen species (RONS), reactive carbonyl species, products of lipid peroxidation. The ROS are superoxide (O2–⋅), singlet oxygen (1O2), hydrogen peroxide (H2O2), and hydroxyl radicals (OH⋅). Reactive nitrogen species include nitrous anhydride (N2O3) and peroxynitrite (ONOO–). They bring about deaminating reactions on guanosine and adenosine (see Table 1).

Level of DNA Breaks With Oxygen Tension

Oxidative damage causes profound effects on the genetic composition by affecting the nuclear and mitochondrial DNA. The relative amounts of such damages if quantified can give an idea regarding the levels of oxidative stress faced by the cell, especially during aging. This has been done previously by various groups using different techniques such as HPLC-EC or GC/MS (see Table 2).

Cellular and Organellar Changes

The aging cell displays certain nucleocytoplasmic features which describe the events that precede and that follow the oxidative damage in various organelles as well as other subcellular compartments. As a part of the normal respiration, ROS such as superoxide is produced from the oxygen consumed, these reactive species interact with iron–sulfur clusters and release free iron, which triggers the downstream release of more reactive oxidant species. Hydrogen peroxide from superoxide produce highly reactive hydroxyl radical that drive the oxidative damage toward the DNA, lipids, and proteins. Mitochondria is a major internal source for ROS and hence is also a major target of oxidative damage; progressive impairment of mitochondria has been implicated in aging and neurodegenerative disorders such as Alzheimer’s. The mitochondrial DNA (mtDNA) is vulnerable to the insults of ROS as they lack histones. The mtDNA has been reported to show increasing levels of oxidized nucleoside 8-hydroxy-2′-deoxyguanosine (OH8dG) with oxidative damage that gradually increases with aging and has been observed in Alzheimer’s as well. Apart from mitochondrial DNA damage, models of premature aging also shows a disruption in DNA repair through defective repair proteins such as Ku86 as well as impairment of transcription-coupled repair of RNA polymerase II stalling lesions. The age-associated oxidative stress may be a common pathogenetic factor in the neurodegenerative disorders that show occurrence of cytoplasmic aggregates, which may be due to p62 and cytokeratins accumulation and aggregation with misfolded proteins. In case of comorbidities of Alzheimer’s such as Idiopathic normal pressure hydrocephalus, there have been reported mitochondria-endoplasmic reticulum contact (MERC) sites. These sites are said to be in a feedback-loop type regulation, wherein these sites can regulate the amyloid β-peptide (Aβ peptide) and the peptide can regulate these sites. These MERC sites were reported to increase in patients with dementia. Lysosomes exhibit increased accumulation of partially digested or damaged matter carried from the inhibited proteasomal activity. Proteasome inhibition also brought about an increase in the levels of mitochondrial ROS, loss of mitochondrial homeostasis and led to increased autophagy that might lead to brain aging. This has been observed in pathological conditions of Alzheimer’s, where there is accumulation of soluble Aβ peptide in the lysosomes. The damage by oxidative stress is seen to build up on nuclear pores. It alters nucleocytoplasmic transport as it affects nuclear lamina components. Aging also caused loss of nuclear pore protein such as Nup93. Aged neurons of rats possessed leaky nuclei and also accumulation of intranuclear tubulin bIII which caused severe chromatin aberrations. Phosphorylated tau which is characteristic of Alzheimer’s alters the transport across the nucleocytoplasmic axis. This was shown to occur by direct interactions with a nuclear pore protein Nup98 in the pore complex and alter nucleocytoplasmic transport in the hippocampal neurons.

In terms of energy metabolism, the metabolite NAD+ and its associated histone deacetylase (HDAC) enzymes- sirtuins show significant decrease in aging and associated increased oxidative stress, causing catabolic breakdown of NAD+. Neuronal and axonal protection was achieved through increased NAD+ generation as well as downstream activation of the sirtuins, SIRT1. These characteristics are affected in neurodegenerative diseases such as Alzheimer’s and Parkinson’s. NAD+ depletion in aging could be due to PARP [poly (ADP-ribose) polymerase], which has been reported to show increased expression in cells from Alzheimer’s and Parkinson’s patients. On the genetic level, brain aging attributes certain cognition specific changes. Cognition in terms of synaptic plasticity and memory are regulated by the expression of certain immediate-early genes such as arc, bdnf, zif268, c-fos, and Egr1. Most of the immediate early genes are involved to be regulating functions of Ca2+ regulation, myelin turnover, vesicular transport, synaptic plasticity as well as energy metabolism and they are known to decrease in transcription with aging. Reduced expression of these genes in adult brain hampers memory consolidation and occurs in normal aging as well as memory disorders.

Changes at the Epigenetic Level

A longitudinal study on a sample size of 104, performed with data on episodic memory as a parameter for tests, showed that the epigenetic DNA-methylation age predicted dementia significantly when compared to the chronological age. The same study has also shown associations with the epigenetic age with cognitive impairment, deteriorating working memory. The group that displayed maintained cognition at an older age of 70–80 had a younger epigenetic age when compared to the baseline levels of those at the age of 55–65. Apart from modifications that happens during gene expression, learning and memory are said to be driven by an “epigenetic code.” Changes in this could lead to cognitive impairment particularly in learning and memory. Various signature patterns have been observed to be involved in the behavior patterns and these are the behavioral changes that are seen to be prominent in the process of aging (see Table 3). It is highly likely that the epigenetic landscape involved in such behavioral aspects of learning and memory is affected with aging.

DNA methylation is one among the epigenetic regulators of gene expression and is controlled through family of enzymes, DNMTs (DNA methyl transferases). They take part in establishing spatial memory and also in fear conditioning. DNMTs catalyze the methylation of the nucleotide cytosine at its 5th carbon to form 5-methyl cytosine (5mC). These 5mC are usually found in CpG dinucleotides in stretches of DNA termed “CpG islands.” The mammalian brain shows approximately 62% methylated CpGs. These islands have been studied to regulate gene expression through mechanisms such as CpG methylation. DNMTs rely on methyl group donors such as L-methylfolate via SAM, however, there is deficiency of folate observed in aging as well as cases of dementia, parallel to the decrease in global methylation with aging. Increased methylation at the PP1 gene and decreased methylation at the reelin gene underlie conditioned fear memory. Similarly, BDNF has been studied to be strongly linked to enduring fear memories through the suppression of its fourth exon by promoter methylation. While methylation at promoters of first and sixth exons led to increased transcription of the gene. These changes are reversed within 24 h and occur in the hippocampus where memory formation occurs. However, memory storage in the prefrontal cortex was coinciding with persistent methylation at the CpG rich promoter of calcineurin. These studies showed that treatment with DNMT inhibitors at the hippocampus gave mixed results due to the dual role of methyl adding and removing activities whereas treatment at the prefrontal cortex prevented retrieval of the fear memory. These modifications also interact and lead to other epigenetic regulators such as HDACs to bring about suppression of the genes. Apart from methylation, hydroxymethyl cytosine formed by the oxidative environment as well as through the catalytic activity of methylcytosine dioxygenase TET1, is known to bring about changes in the expression of certain genes such as Tdg, Apobec1, Smug, and Mbd4. This has been studied to affect long-term associative memory, its formation as well as consolidation. Chromatin remodeling occurs through covalent modifications to the histone core proteins- acetylation, phosphorylation in establishing long-term memory. Mitogen- and stress-activated protein kinase-1 (MSK1) is a major phosphorylating kinase that target H3 histones and other signaling molecules such as cAMP response element-binding protein (CREB) and other transcription factors involved in synaptic plasticity and memory. MSK1 shows high expression in the hippocampus and the double knockout models lack in long-term contextual fear memory but are not affected in terms of short-term associative memory of fear. These models also show a deficit in spatial learning and display an impairment in passive avoidance learning. The kinase acts on ERK to regulate histone modifications post fear training- H3 phosphorylation at Ser 10 and acetylation at Lys 14, which indicate transcriptional activation.

Upregulated histone acetylation post-treatment with HDAC inhibitors has been shown to enhance memory formation and LTP. Other similar studies pertaining to histone acetylation have been shown to be linked to activated gene expression of those that regulate cognition pertaining functions such as increased hippocampal synaptic connectivity/plasticity, LTP. Acetylation at H3 and H4 are generally linked with associative learning, conditioned fear memory- long-term storage and consolidation which have been studied to decrease with aging. These modifications usually occur at promoter regions of genes such as Fmn2 (formin 2), Nr4a1, Nr4a2 (nuclear receptor subfamily 4 group A member 1 and 2), NGFI-B (nerve growth factor I-B) which are known to take part in regulation of cytoskeletal structures, LTP, hippocampal dependent memory storage. Similar study revealed a multiple background changes in the epigenome with aging and highlighted that with aging there is also a region-wise change. It showed H3 acetylation at Lys 9 to be decreased in hippocampal CA1 region, no changes in DG (dentate gyrus) or CA3, whereas, H4 acetylation showed an opposite regulation with aging, increased in CA1 and reduced in DG. These changes were noted as with normal aging accompanied cognitive impairment in terms of spatial learning and memory. H2B acetylation at Lys 5, 12, 15, 20, and H4 acetylation at Lys 12 affect spatial memory and its consolidation. These changes affect genes such as bdnf, cFos, FosB, and zif268.

Oxidative stress in form of ROS induced DNA lesions can influence and alter the methylome landscape in a cell, by means of DNA oxidation and TET-mediated hydroxymethylation. These lesions are pyrimidine hydroxylation products and 5-methylcytosine (5mC). They could interfere with the actual 5-hmC signals by their structural similarities. DNA lesions such as 8-oxoguanine could be repaired through mechanisms of base excision repair (BER) through enzyme 8-oxoG glycosylase (OGG1), however, it has also been shown to be involved in demethylation of methyl-CpGs from 5mC to cytosine, this could lead to changes in the epigenetic signatures of the genes and hence their expression. CpG sites demethylation plays roles in memory formation as well as consolidation in hippocampus and the cingulate cortex. Oxidative stress could also lead to oxidation followed by deamination of the oxidized 5mC. Cytosine and 5-methylcytosine give rise to varied products under the stress of ROS such as hydroxyl anions (see Table 1). Oxidation of cytosine would be a major factor as it enables its deamination to bring about GC → AT transitions.

Studies showed that hippocampal cells from Alzheimer’s patients had decreased global methylation as well as hydroxymethylation. Oxidative stress has the ability to alter methylation and histone acetylation, and hence may be a determinant regulatory factor that affects the epigenetics of cells. Another example of a reactive oxidant species regulating epigenetics of the aging brain is nitric oxide (NO). NO at appropriate concentrations reported to be neuroprotective; however, at excess concentrations, it has been shown to react with superoxide to form the highly reactive peroxynitrite contributing to the oxidative stress. Sirt1 is known to regulate the production of NO via the acetylation of endothelial nitric oxide synthase (eNOS). The age associated decrease in Sirt1 seems to bring about deregulation of NO synthesis which in turn has a profound impact on various downstream targets of NO including DNA methylation, histone acetylases as well as histone methyltransferases. NO has been shown to have intricate connections with BDNF, which is involved in cognition (learning, memory, and its consolidation), synaptic plasticity, and LTP. BDNF regulates post-synaptically the production of NO in the hippocampal neurons at the dendrites and the soma through TrkB and TrkC based signaling. Reduced BDNF levels in the brain has been studied in the context of downstream result of deregulated NO synthesis, and also resulting cognitive impairment. In the cortex and the hippocampus, NO shows gradual decline with aging. Clinical samples of blood plasma in aged individuals have been studied to show higher levels of NO and has been implicated to loss of auditory-verbal as well as visual-spatial based working memory along with impairment of short term declarative memory. Aβ protein disrupts NO activity while impairing the synapses and LTP in Alzheimer’s disease.

The oxidative environment does seem to play an influence in regulating epigenetic machinery and the resulting epigenome of the aging cell. This affects certain characteristics of the cellular system in terms of plasticity and transmission efficacy that ultimately alter cognition to become prone to a gradual decline (Figure 1).

Evolving Theories of Aging

The long-established theory that was made to attempt explaining the mechanism underlying aging explains it as the accumulating cellular and molecular damage through reactive oxidant species, is well known as the Free radical theory. There are now several theories as well as updated versions to this theory with better explanations to the demerits. One among them which is finding favors among many in the field of aging research is the damage theory. A strong argument that the damage theory poses is that the although antioxidants such as mitochondrial SOD seem to ameliorate conditions that prevail in oxidative stress situations, they don’t seem to extend the life span through overexpression. A recent theory that explains the mechanisms that prevail during aging is the epigenetic oxidative redox shift (EORS) theory. It attempts to explain the shift in metabolism with aging. It states the probable increased glycolysis that is brought about through the impaired mitochondrial system, which would ultimately result in increased ROS production. This is carried out by the upregulation of the redox-sensitive transcription factors. The upstream shift is said to be toward oxidized metabolic shift which is due to reduced bursts of energy requirement that is resultant of sedentary lifestyle or lower physical activity. The shift is epigenetically regulated through chromatin modulators - HDACs such as sirtuins, histone acetylases as well as DNMTs. This is accompanied by insulin resistance.

Molecular Targets - A Strategy Aiming for Therapy

The process of oxidative damage has opened avenues for probable targets that either aid in apoptotic inhibition, reducing ROS, modulate chromatin architecture to keep learning and memory associated genes active in transcription. Some of them have been listed below. Quinone reductase 2 is one among the many genes that undergo changes in their hippocampal expression pattern with aging. Its overexpression is reported to be involved in learning deficits that occur in the case of age-related memory impairment. Its selective inhibitors, S26695 and S29434, were able to protect against the toxin menadione-induced apoptosis, preserving and enhancing learning abilities. Similarly, knockout models showed improved motor learning skills.

Human TFAM protein was overexpressed in transgenic mice which suppressed ROS sourced from the mitochondria as well as the inflammatory IL-1β response. It increased the mean EPSP (excitatory postsynaptic potential) when compared to the wild-type aged mice, it ameliorated the working memory as well the hippocampal LTP. Treatment with spin-trapping compound N-tert-butyl-α-phenylnitrone (PBN) helped to cut down the increasing reserves of ROS and prevented early loss of glutamine synthetase activity. The treatment also reduced error rate in radial arm tests indicating that cognitive dysfunction does result from the accumulation of oxidant species, oxidized proteins and products; this impairment in cognition induced through oxidative stress is rescued through the treatment with spin trap moieties, however, this was later observed to be species specific. Epigenetic mechanisms such as histone deacetylation could be inhibited via HDAC inhibitors such as suberoylanilide hydroxamic acid (SAHA). This inhibits class I HDACs and has been observed to induce expression of learning and memory genes in aged mice. The same compound along with other HDAC inhibitors such as sodium valproate and sodium butyrate have been studied to rescue the long-term memory deficits in case of contextual memory in Alzheimer’s disease mice models. HDACI I2 and W2 brought about increased mRNA levels of Aβ degradation enzymes as well as decreased Aβ levels and rescued learning and memory deficits in aged mice Alzheimer’s model- hAPP 3x Tg AD. The HDACI W2 also decreased tau phosphorylation at amino acid position threonine-181.

Another possible target which could also bring about epigenetic regulation through HDAC sirtuins is NAD+. NAD+ is essential as a cofactor, a hydride donor in several metabolic functions necessary for cell’s survival, a key player in energy metabolism- glycolysis, tricarboxylic acid cycle, mitochondrial oxidative phosphorylation (OXPHOS) as well as fatty acid β-oxidation. NAD+ serves as a substrate for SIRT1, to perform its gene regulatory function. Increased levels of NAD+ has been shown to promote more effective SIRT1 activity. NAD+ is seen to be affected with chronic exposure to oxidative stress, which leads to its catabolism. SIRT1 correspondingly showed decreased activity with progressing age.

On the other hand, Sirt1 levels could be regulated by means of certain activators and inhibitors (such as bacterial lipopolysaccharides-LPS). Its activators such as resveratrol have applications in stabilizing cases of epilepsy as well as epilepticus. This could be potential alternative in molecular therapeutic strategies.

L-Arginine as a donor of NO is considered for potential therapeutic application. It showed neuroprotective roles along with NO to bring about amelioration of age induced memory impairment. It also attenuated oxidative stress as well as DNA damage in models of sporadic Alzheimer’s disease.

Future Direction: Toward Healthier Aging

Therapeutic strategies may be devised using multiple approaches to curb the effects of oxidative stress, this could be in the form of caloric restriction coupled with exercise. Physical exercise has been shown to increase the levels of blood flow in the brain vasculature and also to influence BDNF based neuroplasticity. Other approaches could involve nutrition therapy to supplement key players that help in epigenetic regulation with amino acids such as L-arginine, diet with Sirt1 activators, or downstream metabolites such as NAD+, or through quinone reductase inhibitors. Individual therapeutic strategies do not seem to show promising or effective results as there seems to exist a background interconnectivity in the treatment modules toward healthy aging of the brain, that would affect multiple pathways downstream (as shown in Figure 2). Keeping in mind that “we are what we eat” and that there is “no clear-cut definition of normal aging” due to individual based differences. There could be substantial opportunities toward discovering pathways to healthy aging.

Conclusion

When observing the cellular background of cognitive decline, various aspects come into the picture that seem to be the basis of pathogenesis- oxidative stress and its associated damage, vast changes in the metabolic landscape, epigenetic variations, all of which accompany organellar dysfunction and the shortfall in repair and recovery mechanisms. Most of the studies highlight the significant association between aging and oxidative stress; however, still more studies have to be conducted that can show a direct causal link between the two. There is an increasing number of studies that point toward the epigenetic regulation of cognition through several mechanisms that affect the genes involved in learning and memory. Such that there might be a histone code that is involved in the regulation of cognition that may be impacted during aging. All the studies converge to a point that highlight the presence of oxidative stress in the aging cells, cognition in particular is affected via various mechanisms at the gene, nucleocytoplasmic and mostly the epigenetic level. Each component could pose as targets for therapy for symptomatic therapy but for a holistic approach several strategies that also involve epigenetic machinery would prove to be ideal. There is a need for longitudinal studies in vivo and in humans to understand an overall perspective to understanding the placement of aging and its associated diseases. Longitudinal studies in aging animal models (natural and/or induced) and further into humans involving a combined therapeutic strategy of regulated lifestyle modules that incorporate the above-mentioned therapeutic concepts could help understand the fundamental pathology of aging and hence determine effective regulation of healthy aging. There also seems to be several lacunae in understanding the models (D-galactose induced, accelerated senescence, delayed aging, transgenic) to understand aging does not account for the complete pathology of aging. As aging has multiple confounding factors that play a role in determining the level of damage (multiple morbidities), it would be necessary to understand the combined effects of multiple factors to establish causal links between aging and oxidative stress and also the associated cognitive impairment.

Author Contributions

AK synthesized and generally organized the manuscript, Figures 1, 2, and Tables 1–3. GG and KS supervised and edited the manuscript. AK declared that substantially contributed to the review article in object.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 150

  1. 1.

    Alonso M. Bekinschtein P. Cammarota M. Vianna M. R. M. Izquierdo I. Medina J. H. (2005 ). Endogenous BDNF is required for long-term memory formation in the rat parietal cortex. Learn. Mem. 12 504–510.

    Not in our library10.1101/lm.27305

  2. 2.

    Araki T. Sasaki Y. Milbrandt J. (2004 ). Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 1010–1013.

    Not in our library10.1126/science.1098014

  3. 3.

    Banoujaafar H. Monnier A. Pernet N. Quirié A. Garnier P. Prigent-Tessier A. (2016 ). Brain BDNF levels are dependent on cerebrovascular endothelium-derived nitric oxide. Eur. J. Neurosci. 44 2226–2235.

    Not in our library10.1111/ejn.13301

  4. 4.

    Barter J. D. Foster T. C. (2018 ). Aging in the brain: new roles of epigenetics in cognitive decline. Neuroscientist 24 516–525.

    Not in our library10.1177/1073858418780971

  5. 5.

    Bedalov A. Simon J. A. (2004 ). NAD to the rescue. Science 305 954–955.

    Not in our library10.1126/science.1102497

  6. 6.

    Bekinschtein P. Cammarota M. Katche C. Slipczuk L. Rossato J. I. Goldin A. (2008 ). BDNF is essential to promote persistence of long-term memory storage. Proc. Natl. Acad. Sci. U.S.A. 105 2711–2716.

    Not in our library10.1073/pnas.0711863105

  7. 7.

    Benoit C.-E. Bastianetto S. Brouillette J. Tse Y. Boutin J. A. Delagrange P. (2010 ). Loss of quinone reductase 2 function selectively facilitates learning behaviors. J. Neurosci. 30 12690–12700.

    Not in our library10.1523/jneurosci.2808-10.2010

  8. 8.

    Berr C. Balansard B. Arnaud J. Roussel A.-M. Alpérovitch A. Group E. V. A. S. (2000 ). Cognitive decline is associated with systemic oxidative stress: the EVA study. J. Am. Geriatr. Soc. 48 1285–1291.

    Not in our library10.1111/j.1532-5415.2000.tb02603.x

  9. 9.

    Bienvenu C. Cadet J. (1996 ). Synthesis and kinetic study of the deamination of the cis diastereomers of 5,6-dihydroxy-5,6-dihydro-5-methyl-2‘-deoxycytidine. J. Org. Chem. 61 2632–2637.

    Not in our library10.1021/jo951900e

  10. 10.

    Bienvenu C. Wagner J. R. Cadet J. (1996 ). Photosensitized oxidation of 5-Methyl-2‘-deoxycytidine by 2-Methyl-1,4-naphthoquinone: characterization of 5-(Hydroperoxymethyl)-2‘-deoxycytidine and stable methyl group oxidation products. J. Am. Chem. Soc. 118 11406–11411.

    Not in our library10.1021/ja962073h

  11. 11.

    Blalock E. M. Chen K.-C. Sharrow K. Herman J. P. Porter N. M. Foster T. C. (2003 ). Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J. Neurosci. 23 3807–3819.

    Not in our library10.1523/jneurosci.23-09-03807.2003

  12. 12.

    Bousiges O. Vasconcelos A. P. de Neidl R. Cosquer B. Herbeaux K. Panteleeva I. (2010 ). Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus. Neuropsychopharmacology 35 2521–2537.

    Not in our library10.1038/npp.2010.117

  13. 13.

    Boveris A. (1984 ). Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Oxygen Radic. Biol. Syst. 105 429–435.

    Not in our library10.1016/s0076-6879(84)05060-6

  14. 14.
  15. 15.

    Brewer G. J. (2010 ). Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories. Exp. Gerontol. 45 173–179.

    Not in our library10.1016/j.exger.2009.11.007

  16. 16.

    Burcham P. C. (1999 ). Internal hazards: baseline DNA damage by endogenous products of normal metabolism. Mutat. Res. Toxicol. Environ. Mutagen. 443 11–36.

    Not in our library10.1016/s1383-5742(99)00008-3

  17. 17.

    Bürkle A. Beneke S. Muiras M.-L. (2004 ). Poly (ADP-ribosyl) ation and aging. Exp. Gerontol. 39 1599–1601.

    Not in our library10.1016/j.exger.2004.07.010

  18. 18.

    Burney S. Caulfield J. L. Niles J. C. Wishnok J. S. Tannenbaum S. R. (1999 ). The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. Mol. Mech. Mutagen. 424 37–49.

    Not in our library10.1016/s0027-5107(99)00006-8

  19. 19.

    Canossa M. Giordano E. Cappello S. Guarnieri C. Ferri S. (2002 ). Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 99 3282–3287.

    Not in our library10.1073/pnas.042504299

  20. 20.

    Carney J. M. Starke-Reed P. E. Oliver C. N. Landum R. W. Cheng M. S. Wu J. F. (1991 ). Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 88 3633–3636.

    Not in our library10.1073/pnas.88.9.3633

  21. 21.
  22. 22.
  23. 23.

    Chabita K. Saha A. Mandal P. C. Bhattacharyya S. N. Rath M. C. Mukherjee T. (1996 ). Reactions of OH and eaq- adducts of cytosine and its nucleosides or nucleotides with Cu (II) ions in dilute aqueous solutions: a steady-state and pulse radiolysis study. Radiat. Res. 146 514–524.

    Not in our library

  24. 24.

    Chance B. Sies H. Boveris A. (1979 ). Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 527–605.

    Not in our library10.1152/physrev.1979.59.3.527

  25. 25.

    Childs B. G. Durik M. Baker D. J. Van Deursen J. M. (2015 ). Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat. Med. 21 1424–1435.

    Not in our library10.1038/nm.4000.cellular

  26. 26.

    Chouliaras L. Mastroeni D. Delvaux E. Grover A. Kenis G. Hof P. R. (2013 ). Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer’s disease patients. Neurobiol. Aging 34 2091–2099.

    Not in our library10.1016/j.neurobiolaging.2013.02.021

  27. 27.

    Chwang W. B. Arthur J. S. Schumacher A. Sweatt J. D. (2007 ). The nuclear kinase mitogen-and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation. J. Neurosci. 27 12732–12742.

    Not in our library10.1523/jneurosci.2522-07.2007

  28. 28.

    Cosi C. Colpaert F. Koek W. Degryse A. Marien M. (1996 ). Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res. 729 264–269.

    Not in our library10.1016/s0006-8993(96)00571-9

  29. 29.

    Critchley M. (1984 ). And all the daughters of musick shall be brought low: language function in the elderly. Arch. Neurol. 41 1135–1139.

    Not in our library10.1001/archneur.1984.04050220029009

  30. 30.

    Cutler R. G. Mattson M. P. (2006 ). Introduction: the adversities of aging. Ageing Res. Rev. 5 221–238.

    Not in our library10.1016/j.arr.2006.05.002

  31. 31.

    D’Angelo M. A. Raices M. Panowski S. H. Hetzer M. W. (2009 ). Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell 136 284–295.

    Not in our library10.1016/j.cell.2008.11.037

  32. 32.

    De Boer J. Andressoo J. O. de Wit J. Huijmans J. Beems R. B. van Steeg H. (2002 ). Premature aging in mice deficient in DNA repair and transcription. Science 296 1276–1279.

    Not in our library10.1126/science.1070174

  33. 33.

    De Bont R. van Larebeke N. (2004 ). Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 19 169–185.

    Not in our library10.1093/mutage/geh025

  34. 34.

    Deak M. Clifton A. D. Lucocq J. M. Alessi D. R. (1998 ). Mitogen-and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17 4426–4441.

    Not in our library10.1093/emboj/17.15.4426

  35. 35.

    DeFedericis H.-C. Patrzyc H. B. Rajecki M. J. Budzinski E. E. Iijima H. Dawidzik J. B. (2006 ). Singlet oxygen-induced DNA damage. Radiat. Res. 165 445–451.

    Not in our library10.1667/rr3533.1

  36. 36.

    Degerman S. Josefsson M. Adolfsson A. N. Wennstedt S. Landfors M. Haider Z. (2017 ). Maintained memory in aging is associated with young epigenetic age. Neurobiol. Aging 55 167–171.

    Not in our library10.1016/j.neurobiolaging.2017.02.009

  37. 37.

    Ditaranto K. Tekirian T. L. Yang A. J. (2001 ). Lysosomal membrane damage in soluble Aβ-mediated cell death in Alzheimer’s disease. Neurobiol. Dis. 8 19–31.

    Not in our library10.1006/nbdi.2000.0364

  38. 38.

    Donato A. J. Magerko K. A. Lawson B. R. Durrant J. R. Lesniewski L. A. Seals D. R. (2011 ). SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J. Physiol. 589 4545–4554.

    Not in our library10.1113/jphysiol.2011.211219

  39. 39.

    Douki T. Cadet J. (1996 ). Peroxynitrite mediated oxidation of purine bases of nucleosides and isolated DNA. Free Radic. Res. 24 369–380.

    Not in our library10.3109/10715769609088035

  40. 40.

    Dubey H. Gulati K. Ray A. (2017 ). Effects of Nitric Oxide (NO) modulators on cognitive function and brain oxidative stress in experimental model of Alzheimer’s Disease in rats. J. Pharmacol. Rep. 2:126.

    Not in our library

  41. 41.

    Duke C. G. Kennedy A. J. Gavin C. F. Day J. J. Sweatt J. D. (2017 ). Experience-dependent epigenomic reorganization in the hippocampus. Learn. Mem. 24 278–288.

    Not in our library10.1101/lm.045112.117

  42. 42.

    Eftekharzadeh B. Daigle J. G. Kapinos L. E. Coyne A. Schiantarelli J. Carlomagno Y. (2018 ). Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease. Neuron 99 925.e–940.e.

    Not in our library10.1016/j.neuron.2018.07.039

  43. 43.

    Eichenbaum H. (2001 ). The hippocampus and declarative memory: cognitive mechanisms and neural codes. Behav. Brain Res. 127 199–207.

    Not in our library10.1016/s0166-4328(01)00365-5

  44. 44.

    Elobeid A. Libard S. Leino M. Popova S. N. Alafuzoff I. (2016 ). Altered proteins in the aging brain. J. Neuropathol. Exp. Neurol. 75 316–325.

    Not in our library10.1093/jnen/nlw002

  45. 45.

    Evola M. Hall A. Wall T. Young A. Grammas P. (2010 ). Oxidative stress impairs learning and memory in apoE knockout mice. Pharmacol. Biochem. Behav. 96 181–186.

    Not in our library10.1016/j.pbb.2010.05.003

  46. 46.

    Fang E. F. Lautrup S. Hou Y. Demarest T. G. Croteau D. L. Mattson M. P. (2017 ). NAD+ in aging: molecular mechanisms and translational implications. Trends Mol. Med. 23 899–916.

    Not in our library10.1016/j.molmed.2017.08.001

  47. 47.

    Fasolino M. Zhou Z. (2017 ). The crucial role of DNA Methylation and MeCP2 in neuronal function. Genes 8:141.

    Not in our library10.3390/genes8050141

  48. 48.

    Feng J. Zhou Y. Campbell S. L. Le T. Li E. Sweatt J. D. (2010 ). Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 13 423–430.

    Not in our library10.1038/nn.2514

  49. 49.

    Foksinski M. Rozalski R. Guz J. Ruszkowska B. Sztukowska P. Piwowarski M. (2004 ). Urinary excretion of DNA repair products correlates with metabolic rates as well as with maximum life spans of different mammalian species. Free Radic. Biol. Med. 37 1449–1454.

    Not in our library10.1016/j.freeradbiomed.2004.07.014

  50. 50.

    Forster M. J. Dubey A. Dawson K. M. Stutts W. A. Lal H. Sohal R. S. (1996 ). Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. U.S.A. 93 4765–4769.

    Not in our library10.1073/pnas.93.10.4765

  51. 51.

    Fraga C. G. Shigenaga M. K. Park J. W. Degan P. Ames B. N. (1990 ). Oxidative damage to DNA during aging: 8-hydroxy-2’-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. U.S.A. 87 4533–4537.

    Not in our library10.1073/pnas.87.12.4533

  52. 52.

    Fukui K. Onodera K. Shinkai T. Suzuki S. Urano S. (2001 ). Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems. Ann. N. Y. Acad. Sci. 928 168–175.

    Not in our library10.1111/j.1749-6632.2001.tb05646.x

  53. 53.

    Furukawa A. Tada-Oikawa S. Kawanishi S. Oikawa S. (2007 ). H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell. Physiol. Biochem. 20 45–54.

    Not in our library10.1159/000104152

  54. 54.
  55. 55.

    Gu X. Sun J. Li S. Wu X. Li L. (2013 ). Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production. Neurobiol. Aging 34 1069–1079.

    Not in our library10.1016/j.neurobiolaging.2012.10.013

  56. 56.

    Halliwell B. (1992 ). Reactive oxygen species and the central nervous system. J. Neurochem. 59 1609–1623.

    Not in our library10.1111/j.1471-4159.1992.tb10990.x

  57. 57.

    Halliwell B. Gutteridge J. M. C. (1985 ). Free Radicals in Biology and Medicine. Oxford: Clarendon Press.

    Not in our library10.1016/0748-5514(85)90028-5

  58. 58.

    Hamilton M. L. Guo Z. Fuller C. D. Van Remmen H. Ward W. F. Austad S. N. (2001 ). A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res. 29 2117–2126.

    Not in our library10.1093/nar/29.10.2117

  59. 59.

    Harman D. (1956 ). Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 298–300.

    Not in our library10.1093/geronj/11.3.298

  60. 60.

    Harman D. (1968 ). Free radical theory of aging: effect of free radical reaction inhibitors on the mortality rate of male LAF1 mice. J. Gerontol. 23 476–482.

    Not in our library10.1093/geronj/23.4.476

  61. 61.

    Hayashi Y. Yoshida M. Yamato M. Ide T. Wu Z. Ochi-Shindou M. (2008 ). Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J. Neurosci. 28 8624–8634.

    Not in our library10.1523/jneurosci.1957-08.2008

  62. 62.

    Hindle J. V. (2010 ). Ageing, neurodegeneration and Parkinson’s disease. Age Ageing 39 156–161.

    Not in our library10.1093/ageing/afp223

  63. 63.

    Hosseini M. Pourganji M. Khodabandehloo F. Soukhtanloo M. Zabihi H. (2012 ). Protective effect of l-arginine against oxidative damage as a possible mechanism of its Bene. cial properties on spatial learning in ovariectomized rats. Basic Clin. Neurosci. 3 36–44.

    Not in our library

  64. 64.

    Hu D. Serrano F. Oury T. D. Klann E. (2006 ). Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci. 26 3933–3941.

    Not in our library10.1523/jneurosci.5566-05.2006

  65. 65.

    Jessop P. Toledo-Rodriguez M. (2018 ). Hippocampal TET1 and TET2 expression and DNA hydroxymethylation are affected by physical exercise in aged mice. Front. Cell Dev. Biol. 6:45.

    Not in our library10.3389/fcell.2018.00045

  66. 66.

    Jones D. P. (2006 ). Redefining oxidative stress. Antioxid. Redox Signal. 8 1865–1879.

    Not in our library10.1089/ars.2006.8.1865

  67. 67.

    Kaas G. A. Zhong C. Eason D. E. Ross D. L. Vachhani R. V. Ming G. (2013 ). TET1 Controls CNS 5-methylcytosine hydroxylation, Active DNA Demethylation, gene transcription, and memory formation. Neuron 79 1086–1093.

    Not in our library10.1016/j.neuron.2013.08.032

  68. 68.

    Kamsler A. Avital A. Greenberger V. Segal M. (2007 ). Aged SOD overexpressing mice exhibit enhanced spatial memory while lacking Hippocampal neurogenesis. Antioxid. Redox Signal. 9 181–189.

    Not in our library10.1089/ars.2007.9.181

  69. 69.

    Keller J. N. Schmitt F. A. Scheff S. W. Ding Q. Chen Q. Butterfield D. A. (2005 ). Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64 1152–1156.

    Not in our library10.1212/01.wnl.0000156156.13641.ba

  70. 70.

    Kilgore M. Miller C. A. Fass D. M. Hennig K. M. Haggarty S. J. Sweatt J. D. (2010 ). Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer’s disease. Neuropsychopharmacology 35 870–880.

    Not in our library10.1038/npp.2009.197

  71. 71.
  72. 72.

    Klungland A. Rosewell I. Hollenbach S. Larsen E. Daly G. Epe B. (1999 ). Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. U.S.A. 96 13300–13305.

    Not in our library10.1073/pnas.96.23.13300

  73. 73.

    Kolarow R. Kuhlmann C. R. W. Munsch T. Zehendner C. Brigadski T. Luhmann H. J. (2014 ). BDNF-induced nitric oxide signals in cultured rat hippocampal neurons: time course, mechanism of generation, and effect on neurotrophin secretion. Front. Cell. Neurosci. 8:323.

    Not in our library10.3389/fncel.2014.00323

  74. 74.

    Kotambail A. Bhat S. Jayaprakash C. Fernandes R. Varghese V. Satyamoorthy K. (2017 ). Epigenetics and human diseases. Hum. Genom. Appl. 20 73–100.

    Not in our library

  75. 75.

    Kriaucionis S. Heintz N. (2009 ). The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324 929–930.

    Not in our library10.1126/science.1169786

  76. 76.

    Leal N. S. Dentoni G. Schreiner B. Kämäräinen O.-P. Partanen N. Herukka S.-K. (2018 ). Alterations in mitochondria-endoplasmic reticulum connectivity in human brain biopsies from idiopathic normal pressure hydrocephalus patients. Acta Neuropathol. Commun. 6:102.

    Not in our library10.1186/s40478-018-0605-602

  77. 77.

    Levenson J. M. O’Riordan K. J. Brown K. D. Trinh M. A. Molfese D. L. Sweatt J. D. (2004 ). Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem. 279 40545–40559.

    Not in our library10.1074/jbc.m402229200

  78. 78.

    Levine B. Svoboda E. Hay J. F. Winocur G. Moscovitch M. (2002 ). Aging and autobiographical memory: dissociating episodic from semantic retrieval. Psychol. Aging 17 677–689.

    Not in our library10.1037/0882-7974.17.4.677

  79. 79.

    Lewandowska J. Bartoszek A. (2011 ). DNA methylation in cancer development, diagnosis and therapy—multiple opportunities for genotoxic agents to act as methylome disruptors or remediators. Mutagenesis 26 475–487.

    Not in our library10.1093/mutage/ger019

  80. 80.

    Lezak M. Howieson D. Loring D. (2012 ). Neuropsychological Assessment, 5th Edn, Oxford: Oxford University Press.

    Not in our library

  81. 81.

    Lima-Cabello E. Garcia-Guirado F. Calvo-Medina R. El Bekay R. Perez-Costillas L. Quintero-Navarro C. (2016 ). An abnormal nitric oxide metabolism contributes to brain oxidative stress in the mouse model for the fragile X syndrome, a possible role in intellectual disability. Oxid. Med. Cell. Longev. 2016:8548910.

    Not in our library10.1155/2016/8548910

  82. 82.

    Lindahl T. (1993 ). Instability and decay of the primary structure of DNA. Nature 362 709–715.

    Not in our library10.1038/362709a0

  83. 83.

    Lindahl T. Nyberg B. (1972 ). Rate of depurination of native deoxyribonucleic acid. Biochemistry 11 3610–3618.

    Not in our library10.1021/bi00769a018

  84. 84.

    Linnarsson S. Björklund A. Ernfors P. (1997 ). Learning Deficit in BDNF Mutant Mice. Eur. J. Neurosci. 9 2581–2587.

    Not in our library10.1111/j.1460-9568.1997.tb01687.x

  85. 85.

    Liu R. Liu I. Y. Bi X. Thompson R. F. Doctrow S. R. Malfroy B. (2003 ). Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc. Natl. Acad. Sci. U.S.A. 100 8526–8531.

    Not in our library10.1073/pnas.1332809100

  86. 86.

    Love S. (2006 ). Oxidative stress in brain ischemia. Brain Pathol. 9 119–131.

    Not in our library10.1111/j.1750-3639.1999.tb00214.x

  87. 87.

    Love S. Barber R. Wilcock G. K. (1999 ). Increased poly (ADP-ribosyl) ation of nuclear proteins in Alzheimer’s disease. Brain 122 247–253.

    Not in our library10.1093/brain/122.2.247

  88. 88.

    Lubin F. D. Roth T. L. Sweatt J. D. (2008 ). Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J. Neurosci. 28 10576–10586.

    Not in our library10.1523/jneurosci.1786-08.2008

  89. 89.

    Manczak M. Anekonda T. S. Henson E. Park B. S. Quinn J. Reddy P. H. (2006 ). Mitochondria are a direct site of Aβ accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15 1437–1449.

    Not in our library10.1093/hmg/ddl066

  90. 90.

    Martins I. (2017a ). Antimicrobial activity inactivation and toxic immune reactions induce Epilepsy in humans. J. Med. Discov. 2:jmd17040

    Not in our library10.24262/jmd.2.4.17040

  91. 91.

    Martins I. (2017b ). Single gene inactivation with implications to diabetes and multiple organ dysfunction syndrome. J. Clin. Epigenetics 03 1–8.

    Not in our library10.21767/2472-1158.100058

  92. 92.

    Martins I. J. (2017c ). Nutrition therapy regulates caffeine metabolism with relevance to NAFLD and induction of type 3 diabetes. J. Diabetes Metab. Disord. 4 1–9.

    Not in our library10.24966/dmd-201x/100019

  93. 93.
  94. 94.

    Massudi H. Grant R. Guillemin G. J. Braidy N. (2012b ). NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns. Redox Rep. 17 28–46.

    Not in our library10.1179/1351000212y.0000000001

  95. 95.

    Mecocci P. Boccardi V. Cecchetti R. Bastiani P. Scamosci M. Ruggiero C. (2018 ). A long journey into aging, brain aging, and Alzheimer’s Disease following the oxidative stress tracks. J. Alzheimer Dis. 62 1319–1335.

    Not in our library10.3233/jad-170732

  96. 96.

    Mecocci P. MacGarvey U. Beal M. F. (1994 ). Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 36 747–751.

    Not in our library10.1152/ajpendo.00387.2010

  97. 97.

    Mecocci P. MacGarvey U. Kaufman A. E. Koontz D. Shoffner J. M. Wallace D. C. (1993 ). Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 34 609–616.

    Not in our library10.1002/ana.410340416

  98. 98.

    Miller C. A. Gavin C. F. White J. A. Parrish R. R. Honasoge A. Yancey C. R. (2010 ). Cortical DNA methylation maintains remote memory. Nat. Neurosci. 13 664–666.

    Not in our library10.1038/nn.2560

  99. 99.

    Miller C. A. Sweatt J. D. (2007 ). Covalent modification of DNA regulates memory formation. Neuron 53 857–869.

    Not in our library10.1016/j.neuron.2007.02.022

  100. 100.

    Milne J. C. Denu J. M. (2008 ). The Sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 12 11–17.

    Not in our library10.1016/j.cbpa.2008.01.019

  101. 101.

    Misiaszek R. Crean C. Joffe A. Geacintov N. E. Shafirovich V. (2004 ). Oxidative DNA damage associated with combination of guanine and superoxide radicals and repair mechanisms via radical trapping. J. Biol. Chem. 279 32106–32115.

    Not in our library10.1074/jbc.m313904200

  102. 102.

    Mitchell S. J. Scheibye-Knudsen M. Longo D. L. de Cabo R. (2015 ). Animal models of aging research: implications for human aging and age-related diseases. Annu. Rev. Anim. Biosci. 3 283–303.

    Not in our library10.1146/annurev-animal-022114-110829

  103. 103.

    Mockett R. J. Sohal B. H. Sohal R. S. (2010 ). Expression of multiple copies of mitochondrially targeted catalase or genomic Mn superoxide dismutase transgenes does not extend the life span of Drosophila melanogaster. Free Radic. Biol. Med. 49 2028–2031.

    Not in our library10.1016/j.freeradbiomed.2010.09.029

  104. 104.

    Murman D. L. (2015 ). The impact of age on cognition. Semin. Hear. 36 111–121.

    Not in our library10.1055/s-0035-1555115

  105. 105.

    Nagai T. Yamada K. Kim H.-C. Kim Y.-S. Noda Y. Imura A. (2002 ). Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J. 17 50–52.

    Not in our library10.1096/fj.02-0448fje

  106. 106.

    Navarro A. Sánchez Del Pino M. J. Gómez C. Peralta J. L. Boveris A. (2002 ). Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. Am. J. Physiol. Integr. Comp. Physiol. 282 R985–R992.

    Not in our library10.1152/ajpregu.00537.2001

  107. 107.

    Nieuwenhuis I. L. C. Takashima A. (2011 ). The role of the ventromedial prefrontal cortex in memory consolidation. Behav. Brain Res. 218 325–334.

    Not in our library10.1016/j.bbr.2010.12.009

  108. 108.

    O’Donnell E. Lynch M. A. (1998 ). Dietary antioxidant supplementation reverses age-related neuronal changes. Neurobiol. Aging 19 461–467.

    Not in our library10.1016/s0197-4580(98)00082-7

  109. 109.
  110. 110.

    Padurariu M. Ciobica A. Hritcu L. Stoica B. Bild W. Stefanescu C. (2010 ). Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease. Neurosci. Lett. 469 6–10.

    Not in our library10.1016/j.neulet.2009.11.033

  111. 111.

    Papp G. Witter M. P. Treves A. (2007 ). The CA3 network as a memory store for spatial representations. Learn. Mem. 14 732–744.

    Not in our library10.1101/lm.687407

  112. 112.

    Paul V. Ekambaram P. (2011 ). Involvement of nitric oxide in learning & memory processes. Indian J. Med. Res. 133 471–478.

    Not in our library

  113. 113.

    Paul V. Reddy L. Ekambaram P. (2005 ). A reversal by L-arginine and sodium nitroprusside of ageing-induced memory impairment in rats by increasing nitric oxide concentration in the hippocampus. Indian J. Physiol. Pharmacol. 49:179.

    Not in our library

  114. 114.

    Peleg S. Sananbenesi F. Zovoilis A. Burkhardt S. Bahari-Javan S. Agis-Balboa R. C. (2010 ). Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328 753–756.

    Not in our library10.1126/science.1186088

  115. 115.

    Penner M. R. Roth T. L. Barnes C. A. Sweatt J. D. (2010 ). An epigenetic hypothesis of aging-related cognitive dysfunction. Front. Aging Neurosci. 2:9.

    Not in our library10.3389/fnagi.2010.00009

  116. 116.

    Peters R. (2006 ). Ageing and the brain. Postgrad. Med. J. 82 84–88.

    Not in our library10.1136/pgmj.2005.036665

  117. 117.

    Radi R. (2013 ). Peroxynitrite, a stealthy biological oxidant. J. Biol. Chem. 288 26464–26472.

    Not in our library10.1074/jbc.r113.472936

  118. 118.

    Raff M. C. Whitmore A. V. Finn J. T. (2002 ). Axonal self-destruction and neurodegeneration. Science 296 868–871.

    Not in our library10.1126/science.1068613

  119. 119.

    Reckelhoff J. F. Kellum J. A. Blanchard E. J. Bacon E. E. Wesley A. J. Kruckeberg W. C. (1994 ). Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci. 55 1895–1902.

    Not in our library10.1016/0024-3205(94)00521-4

  120. 120.

    Reddy P. (2006 ). Mitochondrial oxidative damage in aging and Alzheimer’s disease: implications for mitochondrially targeted antioxidant therapeutics. J. Biomed. Biotechnol. 2006:31372.

    Not in our library10.1155/jbb/2006/31372

  121. 121.

    Reynolds E. H. (2002 ). Folic acid, ageing, depression, and dementia. BMJ 324 1512–1515.

    Not in our library10.1136/bmj.324.7352.1512

  122. 122.

    Richter C. Park J. W. Ames B. N. (1988 ). Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U.S.A. 85 6465–6467.

    Not in our library10.1073/pnas.85.17.6465

  123. 123.

    Robins Wahlin T.-B. Wahlin A. Winblad B. Bäckman L. (2001 ). The influence of serum vitamin B12 and folate status on cognitive functioning in very old age. Biol. Psychol. 56 247–265.

    Not in our library10.1016/s0301-0511(01)00079-5

  124. 124.

    Rosi S. Ramirez-Amaya V. Vazdarjanova A. Worley P. F. Barnes C. A. Wenk G. L. (2005 ). Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. J. Neurosci. 25 723–731.

    Not in our library10.1523/jneurosci.4469-04.2005

  125. 125.

    Rowe W. B. Blalock E. M. Chen K.-C. Kadish I. Wang D. Barrett J. E. (2007 ). Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J. Neurosci. 27 3098–3110.

    Not in our library10.1523/jneurosci.4163-06.2007

  126. 126.

    Santulli G. Borras C. Bousquet J. Calzà L. Cano A. Illario M. (2015 ). Models for preclinical studies in aging-related disorders: one is not for all. Transl. Med. 13 4–12.

    Not in our library

  127. 127.

    Serrano F. Klann E. (2004 ). Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res. Rev. 3 431–443.

    Not in our library10.1016/j.arr.2004.05.002

  128. 128.

    Socco S. Bovee R. C. Palczewski M. B. Hickok J. R. Thomas D. D. (2017 ). Epigenetics: The third pillar of nitric oxide signaling. Pharmacol. Res. 121 52–58.

    Not in our library10.1016/j.phrs.2017.04.011

  129. 129.

    Sohal R. S. Brunk U. T. (1992 ). Mitochondrial production of pro-oxidants and cellular senescence. Mutat. Res. 275 295–304.

    Not in our library10.1016/0921-8734(92)90033-l

  130. 130.

    Sohal R. S. Ku H.-H. Agarwal S. Forster M. J. Lal H. (1994 ). Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 74 121–133.

    Not in our library10.1016/0047-6374(94)90104-x

  131. 131.

    Soloaga A. Thomson S. Wiggin G. R. Rampersaud N. Dyson M. H. Hazzalin C. A. (2003 ). MSK2 and MSK1 mediate the mitogen-and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22 2788–2797.

    Not in our library10.1093/emboj/cdg273

  132. 132.

    Stahl S. M. (2010 ). Methylated spirits: epigenetic hypotheses of psychiatric disorders. CNS Spectr. 15 220–230.

    Not in our library10.1017/s1092852900000055

  133. 133.

    Steenken S. (1989 ). Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reactions of their radical cations and e-and OH adducts. Chem. Rev. 89 503–520.

    Not in our library10.1021/cr00093a003

  134. 134.

    Sternberg R. J. Sternberg K. (2011 ). Cognitive Psychology, 6th Edn, California: California State University.

    Not in our library

  135. 135.

    Sullivan P. G. Dragicevic N. B. Deng J.-H. Bai Y. Dimayuga E. Ding Q. (2004 ). Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. 279 20699–20707.

    Not in our library10.1074/jbc.m313579200

  136. 136.

    Sung Y. M. Lee T. Yoon H. DiBattista A. M. Song J. M. Sohn Y. (2013 ). Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer’s disease. Exp. Neurol. 239 192–201.

    Not in our library10.1016/j.expneurol.2012.10.005

  137. 137.

    Swerdlow R. H. Khan S. M. (2004 ). A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease. Med. Hypotheses 63 8–20.

    Not in our library10.1016/j.mehy.2003.12.045

  138. 138.

    Tahiliani M. Koh K. P. Shen Y. Pastor W. A. Bandukwala H. Brudno Y. (2009 ). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324 930–935.

    Not in our library10.1126/science.1170116

  139. 139.

    Talamini L. M. Gorree E. (2012 ). Aging memories: differential decay of episodic memory components. Learn. Mem. 19 239–246.

    Not in our library10.1101/lm.024281.111

  140. 140.

    Talarowska M. Gałecki P. Maes M. Orzechowska A. Chamielec M. Bartosz G. (2012 ). Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder. Neurosci. Lett. 510 127–131.

    Not in our library10.1016/j.neulet.2012.01.018

  141. 141.

    Twiss K. C. (2007 ). We Are What We Eat. The Archaeology of Food and Identity. Illinois: Southern Illinois University.

    Not in our library

  142. 142.
  143. 143.

    United Nations (2019 ). World Population Prospects 2019: Highlights (ST/ESA/SER.A/423). New York, NY: United Nations.

    Not in our library

  144. 144.

    Vauzour D. Camprubi-Robles M. Miquel-Kergoat S. Andres-Lacueva C. Bánáti D. Barberger-Gateau P. (2017 ). Nutrition for the ageing brain: towards evidence for an optimal diet. Ageing Res. Rev. 35 222–240.

    Not in our library10.1016/j.arr.2016.09.010

  145. 145.

    Vecsey C. G. Hawk J. D. Lattal K. M. Stein J. M. Fabian S. A. Attner M. A. (2007 ). Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J. Neurosci. 27 6128–6140.

    Not in our library10.1523/jneurosci.0296-07.2007

  146. 146.
  147. 147.

    Wallace D. C. (2012 ). Mitochondria and cancer. Nat. Rev. Cancer 12 685–698.

    Not in our library10.1038/nrc3365

  148. 148.

    Zatloukal K. Stumptner C. Fuchsbichler A. Heid H. Schnoelzer M. Kenner L. (2002 ). p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160 255–263.

    Not in our library10.1016/s0002-9440(10)64369-6

  149. 149.

    Zhou X. Zhuang Z. Wang W. He L. Wu H. Cao Y. (2016 ). OGG1 is essential in oxidative stress induced DNA demethylation. Cell. Signal. 28 1163–1171.

    Not in our library10.1016/j.cellsig.2016.05.021

  150. 150.

    Zuo S. Boorstein R. J. Teebor G. W. (1995 ). Oxidative damage to 5-methylcytosine in DNA. Nucleic Acids Res. 23 3239–3243.

    Not in our library10.1093/nar/23.16.3239

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.